NeoGenomics Launches New Test for Detection of Mutations in Calreticulin Gene
January 07, 2014 at 07:15 AM EST
NeoGenomics (NASDAQ: NEO ) announced today that it has validated and launched a new test for the detection of mutations in the calreticulin (CALR) gene. The CALR gene is a novel biomarker that was reported to be specific for myeloproliferative neoplasms (MPN) for the first time at the annual